Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Mongon ThibautExec VP, WW Chair, Consumer
|
Tax withholdingCommon Stock | 694 | $150.46 | $104,419.24 |
DisclosureSEC source: 0001225208-20-002663 · doc4.xml · nonDerivative · entry 3 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,565.2661 F3 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Mongon ThibautExec VP, WW Chair, Consumer
|
Exercise / conversionCommon Stock | 1,773 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002663 · doc4.xml · nonDerivative · entry 2 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,259.2661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Mongon ThibautExec VP, WW Chair, Consumer
|
Exercise / conversionCommon Stock | 1,919 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002663 · doc4.xml · nonDerivative · entry 1 Mongon Thibaut · CIK 0001768503 · Exec VP, WW Chair, Consumer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,486.2661 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
Exercise / conversionRestricted Share Units · Derivative | 5,684 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002664 · doc4.xml · derivative · entry 8 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,684 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. F2 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
Exercise / conversionPerformance Share Units · Derivative | 6,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002664 · doc4.xml · derivative · entry 7 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,152 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
Tax withholdingCommon Stock | 2,672 | $150.46 | $402,029.12 |
DisclosureSEC source: 0001225208-20-002664 · doc4.xml · nonDerivative · entry 4 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,079 F4 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
Tax withholdingCommon Stock | 2,468 | $150.46 | $371,335.28 |
DisclosureSEC source: 0001225208-20-002664 · doc4.xml · nonDerivative · entry 3 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,751 F3 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
Exercise / conversionCommon Stock | 5,684 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002664 · doc4.xml · nonDerivative · entry 2 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Sneed Michael EEVP, Global Corp Aff & COO
|
Exercise / conversionCommon Stock | 6,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002664 · doc4.xml · nonDerivative · entry 1 Sneed Michael E · CIK 0001745939 · EVP, Global Corp Aff & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Stoffels PaulusVice Chair, Exec Committee
|
Exercise / conversionRestricted Share Units · Derivative | 11,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002665 · doc4.xml · derivative · entry 6 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,695 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. F2 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Stoffels PaulusVice Chair, Exec Committee
|
Exercise / conversionPerformance Share Units · Derivative | 27,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002665 · doc4.xml · derivative · entry 5 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,686 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Stoffels PaulusVice Chair, Exec Committee
|
Tax withholdingCommon Stock | 12,022 | $150.46 | $1,808,830.12 |
DisclosureSEC source: 0001225208-20-002665 · doc4.xml · nonDerivative · entry 4 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,799.2911 F4 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Stoffels PaulusVice Chair, Exec Committee
|
Tax withholdingCommon Stock | 4,079 | $150.46 | $613,726.34 |
DisclosureSEC source: 0001225208-20-002665 · doc4.xml · nonDerivative · entry 3 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,821.2911 F3 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Stoffels PaulusVice Chair, Exec Committee
|
Exercise / conversionCommon Stock | 11,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002665 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,900.2911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Stoffels PaulusVice Chair, Exec Committee
|
Exercise / conversionCommon Stock | 27,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002665 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,205.2911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Exercise / conversionRestricted Share Units · Derivative | 7,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002666 · doc4.xml · derivative · entry 6 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,724 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. F2 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Exercise / conversionPerformance Share Units · Derivative | 8,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002666 · doc4.xml · derivative · entry 5 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,360 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Tax withholdingCommon Stock | 4,277 | $150.46 | $643,517.42 |
DisclosureSEC source: 0001225208-20-002666 · doc4.xml · nonDerivative · entry 4 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,585.001 F4 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Tax withholdingCommon Stock | 3,951 | $150.46 | $594,467.46 |
DisclosureSEC source: 0001225208-20-002666 · doc4.xml · nonDerivative · entry 3 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,862.001 F3 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Exercise / conversionCommon Stock | 7,724 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002666 · doc4.xml · nonDerivative · entry 2 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,813.001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Taubert Jennifer LEVP, WW Chair, Pharmaceuticals
|
Exercise / conversionCommon Stock | 8,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002666 · doc4.xml · nonDerivative · entry 1 Taubert Jennifer L · CIK 0001745938 · EVP, WW Chair, Pharmaceuticals 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,089.001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Ullmann Michael HExec VP, General Counsel
|
Exercise / conversionRestricted Share Units · Derivative | 6,036 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002667 · doc4.xml · derivative · entry 8 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,036 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. F2 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Ullmann Michael HExec VP, General Counsel
|
Exercise / conversionPerformance Share Units · Derivative | 14,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002667 · doc4.xml · derivative · entry 7 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,290 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Ullmann Michael HExec VP, General Counsel
|
Tax withholdingCommon Stock | 7,219 | $150.46 | $1,086,170.74 |
DisclosureSEC source: 0001225208-20-002667 · doc4.xml · nonDerivative · entry 4 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,283.882 F4 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Ullmann Michael HExec VP, General Counsel
|
Tax withholdingCommon Stock | 2,194 | $150.46 | $330,109.24 |
DisclosureSEC source: 0001225208-20-002667 · doc4.xml · nonDerivative · entry 3 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,502.882 F3 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Ullmann Michael HExec VP, General Counsel
|
Exercise / conversionCommon Stock | 6,036 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002667 · doc4.xml · nonDerivative · entry 2 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,696.882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Ullmann Michael HExec VP, General Counsel
|
Exercise / conversionCommon Stock | 14,290 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002667 · doc4.xml · nonDerivative · entry 1 Ullmann Michael H · CIK 0001537710 · Exec VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,660.882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionRestricted Share Units · Derivative | 3,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002668 · doc4.xml · derivative · entry 7 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. F2 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionPerformance Share Units · Derivative | 3,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002668 · doc4.xml · derivative · entry 6 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,680 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Wolk Joseph JExec VP, CFO
|
Tax withholdingCommon Stock | 1,112 | $150.46 | $167,311.52 |
DisclosureSEC source: 0001225208-20-002668 · doc4.xml · nonDerivative · entry 4 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,296.339 F4 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Wolk Joseph JExec VP, CFO
|
Tax withholdingCommon Stock | 979 | $150.46 | $147,300.34 |
DisclosureSEC source: 0001225208-20-002668 · doc4.xml · nonDerivative · entry 3 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,408.339 F3 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionCommon Stock | 3,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002668 · doc4.xml · nonDerivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,387.339 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionCommon Stock | 3,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002668 · doc4.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,987.339 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
Exercise / conversionRestricted Share Units · Derivative | 7,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002669 · doc4.xml · derivative · entry 8 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,592 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. F2 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
Exercise / conversionPerformance Share Units · Derivative | 8,217 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002669 · doc4.xml · derivative · entry 7 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,217 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
Tax withholdingCommon Stock | 4,203 | $150.46 | $632,383.38 |
DisclosureSEC source: 0001225208-20-002669 · doc4.xml · nonDerivative · entry 4 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,419.5041 F4 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
Tax withholdingCommon Stock | 2,909 | $150.46 | $437,688.14 |
DisclosureSEC source: 0001225208-20-002669 · doc4.xml · nonDerivative · entry 3 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,622.5041 F3 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
Exercise / conversionCommon Stock | 7,592 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002669 · doc4.xml · nonDerivative · entry 2 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,531.5041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC |
Wengel Kathryn EEVP, Chief GSC Officer
|
Exercise / conversionCommon Stock | 8,217 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002669 · doc4.xml · nonDerivative · entry 1 Wengel Kathryn E · CIK 0001745955 · EVP, Chief GSC Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,939.5041 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:09 UTC |
Beckerle Mary CDirector
|
GrantDeferred Share Units · Derivative | 1,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002155 · doc4.xml · derivative · entry 1 Beckerle Mary C · CIK 0001520181 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,616.941 Underlying: Common Stock · 1,221 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:09 UTC |
DAVIS D SCOTTDirector
|
GrantDeferred Share Units · Derivative | 1,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002156 · doc4.xml · derivative · entry 1 DAVIS D SCOTT · CIK 0001227733 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,363.776 Underlying: Common Stock · 1,221 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:09 UTC |
Davis IanDirector
|
GrantDeferred Share Units · Derivative | 1,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002157 · doc4.xml · derivative · entry 1 Davis Ian · CIK 0001494009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,590.872 Underlying: Common Stock · 1,221 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:09 UTC |
HEWSON MARILLYN ADirector
|
GrantDeferred Share Units · Derivative | 1,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002158 · doc4.xml · derivative · entry 1 HEWSON MARILLYN A · CIK 0001217496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,221 Underlying: Common Stock · 1,221 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:09 UTC |
McClellan Mark B.Director
|
GrantDeferred Share Units · Derivative | 1,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002159 · doc4.xml · derivative · entry 1 McClellan Mark B. · CIK 0001567006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,380.897 Underlying: Common Stock · 1,221 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:10 UTC |
PRINCE CHARLESDirector
|
GrantDeferred Share Units · Derivative | 1,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002160 · doc4.xml · derivative · entry 1 PRINCE CHARLES · CIK 0001225179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,343.766 Underlying: Common Stock · 1,221 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:10 UTC |
Washington A. EugeneDirector
|
GrantDeferred Share Units · Derivative | 1,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002161 · doc4.xml · derivative · entry 1 Washington A. Eugene · CIK 0001561989 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,646.0333 Underlying: Common Stock · 1,221 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:10 UTC |
WILLIAMS RONALD ADirector
|
GrantDeferred Share Units · Derivative | 1,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002162 · doc4.xml · derivative · entry 1 WILLIAMS RONALD A · CIK 0001185243 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,149.454 Underlying: Common Stock · 1,221 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:10 UTC |
WEINBERGER MARK ADirector
|
GrantDeferred Share Units · Derivative | 1,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002163 · doc4.xml · derivative · entry 1 WEINBERGER MARK A · CIK 0001785997 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,221 Underlying: Common Stock · 1,221 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:10 UTC |
Joly HubertDirector
|
GrantDeferred Share Units · Derivative | 1,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002164 · doc4.xml · derivative · entry 1 Joly Hubert · CIK 0001467638 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,221 Underlying: Common Stock · 1,221 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 21:10 UTC |
MULCAHY ANNE MDirector
|
GrantDeferred Share Units · Derivative | 1,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002166 · doc4.xml · derivative · entry 1 MULCAHY ANNE M · CIK 0001201725 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,590.872 Underlying: Common Stock · 1,221 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.